FT
Merck transforms itself through dealmaking as clock ticks on top-selling drug
Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda
Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda